Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 2 1

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 2Neoplasms 1Lung Neoplasms 1Cigarette Smoking-Related Carcinoma 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Carbon Monoxide × 1 year × Clear all
NCT06038526 2026-05-20

Evaluation of Canakinumab in High-Risk Former-Smokers

Ohio State University Comprehensive Cancer Center

Phase 2 Active not recruiting
41 enrolled
Thoracic

Lung Neoplasms

NCT03059940 2026-04-15

Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
630 enrolled

Smoking Cessation

NCT05941858 2026-04-02

Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase NA Completed
68 enrolled

Neoplasms, Smoking Cessation

NCT06763536 2025-06-22

ARISE

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
1,000 enrolled

Cigarette Smoking-Related Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡